10X Fund Issues Statement on Exercise of Additional 200,000 Galectin Therapeutics Warrants NICEVILLE, Fla., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Rod D. Martin, Co-Founder and Managing Member of 10X Capital Management, LLC, whose 10X Fund is the largest shareholder in Galectin Therapeutics...

10X Fund Issues Statement on Sale of Shares, Bullish Outlook Regarding Galectin Therapeutics NICEVILLE, Fla., Oct. 17, 2013 (GLOBE NEWSWIRE) -- Rod D. Martin, Co-Founder and Managing Member of 10X Capital Management, LLC, whose 10X Fund is the largest shareholder in Galectin Therapeutics...